Adipose tissue activity in relation to overweight or obesity

Endokrynologia Polska

Volumn 61, Issue 2, 2010, Pages 160-168

  Gnacińska, Maria ^a   Małgorzewicz, Sylwia ^a   Guzek, Marek ^a   Łysiak Szydłowska, Wiesława ^a   Sworczak, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adipokines; Inflammation; Obesity

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; INSULIN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; INSULIN RESISTANCE; LABORATORY TEST; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS;

ADIPOKINES; ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; C-REACTIVE PROTEIN; CYTOKINES; DIET, REDUCING; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; YOUNG ADULT;

EID: 77953481125     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Pudel V. Ellrott T. Adipositas - ein gesellschaftspolitisches Problem? Chirurg 2005; 76: 639-646.
2. Reincke M. Adipositas und Innere Medizin. Internist 2006; 47: 10.
3. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a World Health Organization Consultation. Geneva, Switzerland: World Health Organization, 2000. WHO Obesity Technical Reprt Series, No. 894.
4. Fischer-Posovszky P, Wabitsch M. Entwicklung und Funktion des Fettgewebes. Monatsschr Kinderheilkd 2004; 152: 834-842
5. Smith SR, Wilson PWF. Free Fatty Acids and Atherosclerosis -Guilty or Innocent? J Clin Endocrinol Metab 2006; 91: 2506-2508.
6. Trayhurn P. Adipocyte biology. Obes Rev. 2007; 8 (Suppl.1): 41-44.
7. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocriol Metab 2000; 10: 327-332.
8. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548-2556.
9. Trayhurn P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005; 184: 285-293.
10. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and Insulin Resistance. J Clin Endocrinol Metab 2004; 89: 447-452.
11. Ronti T, Lupattelli G, Monnarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol 2006; 64: 355-365.
12. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Kocełak P et al. The effect of weight reduction on plasma concentrations of ghrelin and insulin-like growth factor 1 in obese women. Pol J Endocrinol 2008; 59: 301-304.
13. Tworowska-Bardzińska U, Kubicka E, Ślȩzak R et al. Lack of relationship between 174G-C promoter polymorphism of the IL-6 gene and indices of metabolic syndrome in non-obese healthy subjects. Pol J Endocrinol 2009; 60: 172-179.
14. Vettor R, Milan G, Rossato M et al. Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther 2005; 22 (Suppl. 2): 3-10. (Pubitemid 41564373)
15. Schäffler A, Müller-Ladner U, Schölmerich J et al. Role of Adipose Tissue as an Inflammatory Organ in Human Diseases. Endocr Rev 2006; 27: 449-467. (Pubitemid 44213227)
16. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6: 772-783. (Pubitemid 44453463)
17. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B. Otyłoś ć jako choroba zapalna. Postepy Hig Med Dośw. 2008; 62: 249-257.
18. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 105: 1010-1019.
19. Ohnishi H, Saitoh S, Takagi S et al. Incidence of insulin resistance in obese subjects in a rural Japanese population: The Tanno and Sobetsu study. Diabetes Obes Metab 2005; 7: 83-87.
20. Magni P, Liuzzi A, Ruscica M et al. Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference. Clin Endocrinol 2005; 62: 189-196. (Pubitemid 40203914)
21. Guagnano MT, Romano M, Falco A et al. Leptin increase is associated with markers of the hemostatic system in obese healthy women. J Thromb Haemost 2003; 1: 2330-2334.
22. Chiou WK, Lin JD, Weng HF et al. Correlation of the Dysmetabolic Risk Factors with Different Anthropometric Measurements. Endocr J 2005; 52: 139-148
23. Marfella R, Esposito K, Siniscalchi M et al. Effect of Weight Loss on Cardiac Synchronization and Proinflammatory Cytokines in Premenopausal Obese Women. Diabetes Care 2004; 27: 47-52. (Pubitemid 38196708)
24. Silha JV, Krsek M, Skrha JV et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endorinol. 2003; 149: 331-335. (Pubitemid 37304704)
25. Bo S, Gambino R, Pagani A et al. Relationship between human serum resistin, inflammatory markers and insulin resistance. Int J Obes 2005; 29: 1315-132.
26. Bruun JM, Lihn AS, Verdich C et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285: E527-E533. (Pubitemid 37010830)
27. Hoffstedt J, Arvidsson E, Sjölin E et al. Adipose Tissue Adiponectin Production and Adiponectin Serum Concentration in Human Obesity and Insulin Resistanece. J Clin Endocrinol Metab 2004; 89: 1391-1396.
28. Blum CA, Mu̇ller B, Huber P et al. Low-Grade Inflammation and Estimates of Insulin Resistance during the Menstrual Cycle in Lean and Overweight Women. J Clin Endocrinol Metab 2005; 90: 3230-3235.
29. Abbatecola AM, Ferrucci L, Grella R et al. Diverse Effect of Inflammatory Markers on Insulin Resistnce and Insulin-Resistance Syndrome in the Elderly. J Am Geriatr Soc 2004; 52: 399-404.
30. Martin LJ, Woo JG, Daniels SR et al. The Relationship of Adiponectin with Insulin and Lipids Are Strengthened with Increasing Adiposity. J Clin Endocrinol Metab 2005; 90: 4255-4259
31. Baratta R, Amato S, Degano C et al. Adiponectin Relationship with Lipid Metabolism is Independent of Body Fat Mass: Evidence from Both Cross-Sectional and Interventional Studies. J Clin Endocrinol Metab 2004; 89: 2665-2671.
32. Staiger H, Tschritter O, Machann J et al. Relationship of Serum Adiponectin and Leptin Concentration with Body Fat Distribution in Humans. Obes Res 2003; 10: 368-372.
33. Walczewska A. Leptyna-nowy hormon. Endokrynol Pol 2000; 51: 125-148
34. Boden G, Chen X, Mozzoli M et al. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996; 81: 3419-3423.
35. Haluzik M, Matoulek M, Svacinas S et al. The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females. Endocr Res 2001; 27: 251-260.
36. Rosenbaum M, Nicolson M, Hirsch J et al. Effect of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab 1997; 82: 3647-365. (Pubitemid 27509351)
37. Chin-Chance C, Polonsky KS, Shoeller DA. Twenty-four-hour leptin levels respond to cumulative short-term energy imbalance and predict subsequent intake. J Clin Endocrinol Metab 2000; 85: 2685-2691. (Pubitemid 32269136)
38. Wolfe BE, Jimerson DC, Orlova Ch et al. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol 2004; 61: 332-338.
39. Saad MF, Damani S, Gingerich RL et al. Sexual dimorphism in plasma leptin concentration.) Clin Endocrinol Metab 1997; 82: 579-584. (Pubitemid 27068633)
40. van Aggel-Leijssen DP, van Baak MA, Tenenbaum R et al. Regulation of average 24h human plasma leptin level; the influence of exercise and physiological changes in energy balance. Int J Obes Relat Metab Disord 1999; 23: 151-158. (Pubitemid 29057509)
41. Malgorzewicz S, Aleksandrowicz-Wrona E, Skrzypczak-Jankun E, Perlińska E, Gnacińska M, Łysiak-Szydłowska W. Zmiany stéżeń leptyny i karnityny oraz zawartości tkanki tłuszczowej u kobiet z nadwaģ lub otyłoś cia̧. Med Metab 2009; 13: 54-63.
42. McTernan PG, Kusminski CM, Kumar S. Resistin. Curr Opin Lipidol 2006; 17: 170-175.
43. Bogdański P, Pupek-Musialik D, Łuczak M et al. Czynnik martwicy nowotworów (TNF-α) w procesie indukcji insulinooporności u osób z otyłościa̧ prosta̧. Diabetologia Doświadczalna i Kliniczna 2002b; 6: 449-454.
44. Aksungar FB, Topkaya AE, Akyildiz M. Interleukin-6, C-reactive protein and biochemical parameters during prolonged intermittent fasting. Ann Nutr Matab 2007, 51: 88-95.
45. de Luis DA, Aller R, Izaola O et al. Effects of a Low-Fat versus a Low-Carbohydrate Diet on Adipoytokines in Obese Adults. Horm Res 2007; 67: 296-300.
46. Xydakis AM, Case CC, Jones PH et al. Adiponectin, Inflammation, and the Expression of the Metabolic Syndrome in Obese Individuals: The Impact of Rapid Weight Loss through Caloric Restriction. J Clin Endocrinol Metab 2004; 89: 2697-2703.
47. Shand BI, Scott RS, Elder PA et al. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistnce. Diabetes Obes Metab 2003; 5: 349-353.
48. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46: 459-469. (Pubitemid 36577787)
49. Kern PA, Di Gregorio GB, Lu T et al. Adiponectin Expression From Human Adipose Tissue. Diabetes 2003; 52: 1779-1785.
50. Côté M, Mauriège P, Bergeron J et al. Adiponectinemia in Visceral Obesity: Impact on Glucose Tolerance and Plasma Lipoprotein and Lipid Levels in Men. J Clin Endocrinol Metab 2005; 90: 1434-1439. (Pubitemid 40464000)
51. Shaibi GQ, Cruz ML, Weigensberg MJ et al. Adiponectin Independently Predict Metabolic Syndrome in Overweight Latino Youth. J Clin Endocrinol Metab 2007; 92: 1809-1813.
52. Ryo M, Nakamura T, Kihara S et al. Adiponectin as a Biomarker of the Metabolic Syndrome. Circ J 2004; 68: 975-981.
53. Shetty GK, Economides PA, Horton ES et al. Circulating Adiponectin and Resistin Levels in Relation to Metabolic Factors, Inflammatory Markers, and Vascular Reactivity in Diabetic Patients and Subjects at Risk for Diabetes. Diabetes Care 2004; 27: 2450-2457.
54. Whitehead JP, Richards AA,Hickman IJ et al. Adiponectin - a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006; 8: 264-280.
55. Satoh N, Naruse M, Usui T, Tagami T, Suganami T, Yamada K, Kuzuya H, Shimatsu A, Ogawa Y. Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients. Diabetes Care 2004; 27: 2488-2490. (Pubitemid 39281406)